Artificial Intelligence in Life Sciences Market Size, Share, Competitive Landscape and Trend Analysis Report, by Types (Adoption of AI across three waves, Application of AI in Lifescieces) and, by Applications (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision and Personalized Medicine, Patient Monitoring, Others): Opportunity Analysis and Industry Forecast, 2023-2032

The report includes potential revenue forecast of the market for the next ten years along with market trends, opportunities, and competition intelligence. In addition, the report offers various intellectual tables and charts/graphs to understand the complexities of the market. The report will help clients in gaining much recent and first-hand insights of overall global market and regional level penetration of each segment. Furthermore, the study comprises information of key players in the market and its financial results, company trends, segmental revenue, product/service offerings, SWOT analysis, and brand positioning.

Besides revenue forecasting, the report will track the recent growth trends, company market share, new product/service launch, and impact of M&A activities across the market. The competition section of the study will highlight the revenue share and potential of leading competitors of the market. The report covers profiling of top 10 competitors of the market. Further, the study includes revenue forecast for 4 regions and 20+ key countries. Readers can find forecasts for the Artificial intelligence in life sciences market in North America, Europe, Asia-Pacific, and LAMEA.

Key Companies identified in the report are Zebra Medical Vision twoXARInc Atomwise Inc NuMediiInc IBM Corporation Lifegraph Limited EnliticInc Cyrcadia Health Inc Insilico MedicineInc NumerateInc APIXIOInc Sensely Inc Sophia Genetics SA AiCureLLC

  Artificial Intelligence in Life Sciences Market Report Highlights

Aspects	Details
By Types	Adoption of AI across three waves Application of AI in Lifescieces
By Applications	Drug Discovery Medical Diagnosis Biotechnology Clinical Trails Precision and Personalized Medicine Patient Monitoring Others
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Insilico MedicineInc, Lifegraph Limited, AiCureLLC, Sensely Inc, NuMediiInc, IBM Corporation, twoXARInc, Atomwise Inc, Sophia Genetics SA, Cyrcadia Health Inc, EnliticInc, NumerateInc, Zebra Medical Vision, APIXIOInc

^*Terms and Conditions Apply